227 related articles for article (PubMed ID: 28866393)
1. Occurrence, distribution and environmental risk of pharmaceutically active compounds (PhACs) in coastal and ocean waters from the Gulf of Cadiz (SW Spain).
Biel-Maeso M; Baena-Nogueras RM; Corada-Fernández C; Lara-Martín PA
Sci Total Environ; 2018 Jan; 612():649-659. PubMed ID: 28866393
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceuticals as chemical markers of wastewater contamination in the vulnerable area of the Ebro Delta (Spain).
Čelić M; Gros M; Farré M; Barceló D; Petrović M
Sci Total Environ; 2019 Feb; 652():952-963. PubMed ID: 30380500
[TBL] [Abstract][Full Text] [Related]
3. The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters.
Fang TH; Nan FH; Chin TS; Feng HM
Mar Pollut Bull; 2012 Jul; 64(7):1435-44. PubMed ID: 22608946
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of pharmaceuticals and personal care products in effluent-dominated Saudi Arabian coastal waters of the Red Sea.
Ali AM; Rønning HT; Alarif W; Kallenborn R; Al-Lihaibi SS
Chemosphere; 2017 May; 175():505-513. PubMed ID: 28249192
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and risks of antibiotics in the coastal aquatic environment of the Yellow Sea, North China.
Zhang R; Tang J; Li J; Cheng Z; Chaemfa C; Liu D; Zheng Q; Song M; Luo C; Zhang G
Sci Total Environ; 2013 Apr; 450-451():197-204. PubMed ID: 23474265
[TBL] [Abstract][Full Text] [Related]
7. Seasonal distribution of pharmaceuticals in marine water and sediment from a Mediterranean coastal lagoon (SE Spain).
Moreno-González R; Rodriguez-Mozaz S; Gros M; Barceló D; León VM
Environ Res; 2015 Apr; 138():326-44. PubMed ID: 25766939
[TBL] [Abstract][Full Text] [Related]
8. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment.
Liu J; Dan X; Lu G; Shen J; Wu D; Yan Z
Ecotoxicol Environ Saf; 2018 Jun; 154():214-220. PubMed ID: 29476970
[TBL] [Abstract][Full Text] [Related]
9. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk.
Valcárcel Y; González Alonso S; Rodríguez-Gil JL; Gil A; Catalá M
Chemosphere; 2011 Sep; 84(10):1336-48. PubMed ID: 21641628
[TBL] [Abstract][Full Text] [Related]
10. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
11. Occurrence and distribution of pharmaceutical compounds in the Danshuei River Estuary and the Northern Taiwan Strait.
Fang TH; Lin CW; Kao CH
Mar Pollut Bull; 2019 Sep; 146():509-520. PubMed ID: 31426188
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical active compounds in a heavily industrialized and urbanized bay, Eastern China.
Sun J; Ke Z; Zhang Y; Wu Q; Chen Y; Tang J
Environ Sci Pollut Res Int; 2023 Apr; 30(18):51624-51637. PubMed ID: 36811780
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard.
Mendoza A; Aceña J; Pérez S; López de Alda M; Barceló D; Gil A; Valcárcel Y
Environ Res; 2015 Jul; 140():225-41. PubMed ID: 25880605
[TBL] [Abstract][Full Text] [Related]
15. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada.
Comeau F; Surette C; Brun GL; Losier R
Sci Total Environ; 2008 Jun; 396(2-3):132-46. PubMed ID: 18377954
[TBL] [Abstract][Full Text] [Related]
16. Sources and trends of artificial sweeteners in coastal waters in the bay of Cadiz (NE Atlantic).
Baena-Nogueras RM; Traverso-Soto JM; Biel-Maeso M; Villar-Navarro E; Lara-Martín PA
Mar Pollut Bull; 2018 Oct; 135():607-616. PubMed ID: 30301079
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of 40 pharmaceutically active compounds in hospital and urban wastewaters and their contribution to Mahdia coastal seawater contamination.
Afsa S; Hamden K; Lara Martin PA; Mansour HB
Environ Sci Pollut Res Int; 2020 Jan; 27(2):1941-1955. PubMed ID: 31768956
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceuticals and other contaminants in waters and sediments from Augusta Bay (southern Italy).
Feo ML; Bagnati R; Passoni A; Riva F; Salvagio Manta D; Sprovieri M; Traina A; Zuccato E; Castiglioni S
Sci Total Environ; 2020 Oct; 739():139827. PubMed ID: 32544676
[TBL] [Abstract][Full Text] [Related]
19. Polar organic micropollutants in the coastal environment of different marine systems.
Nödler K; Voutsa D; Licha T
Mar Pollut Bull; 2014 Aug; 85(1):50-9. PubMed ID: 25015017
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization.
Fernández C; González-Doncel M; Pro J; Carbonell G; Tarazona JV
Sci Total Environ; 2010 Jan; 408(3):543-51. PubMed ID: 19889447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
